Recently, the 2026 "Shenzhen Talent Day" Pingshan District Expert Talent Symposium was held in Pingshan. Professor Wang Jianxun, Chief Scientist of the Cell Valley Group, was invited to attend, joining academicians and expert talent representatives from the district's industry, education, healthcare, and other fields to jointly discuss development.

This event coincided with the tenth "Shenzhen Talent Day" and combined achievement showcases with expert discussions to reflect on a decade of talent cultivation. The symposium, themed "Pingshan's Next Decade: Promoting the Integrated Development of Education, Science and Technology, and Talent to Help Build an Innovative Pingshan and City of the Future," saw participating experts, grounded in the requirements for developing new quality productive forces, engage in discussions on topics including original innovation layout, talent system and mechanism reform, industry-academia-research-medicine interdisciplinary integration, the building of talent pipelines for urgently needed and scarce professionals, and public service support. Together, they explored Pingshan's pathway toward a virtuous cycle among education, science and technology, and talent.

In his remarks, Wang Jianxun stated that cell and gene therapy is a strategic track in the global biopharmaceutical field, and the core of competition has always been proprietary technology and high-end talent. Since establishing its presence in Pingshan, Cell Valley has adhered to a talent-driven approach to technological breakthroughs, building China's first clinical-grade retroviral vector GMP industrial production line, breaking the industry bottleneck of long-term reliance on imports for upstream vectors, and accumulating solid confidence for the company's entry into international markets. Looking toward the next decade, he proposed deepening medical-education collaboration through hospital-enterprise cooperation, advancing hospital-enterprise cooperation toward institutionalization so that clinical needs truly become the starting point for technological breakthroughs; cultivating interdisciplinary medical-engineering talent through a "dual-mentor system," enabling students to enter GMP workshops and real production lines during their studies and connect classroom knowledge with industrial scenarios; and simultaneously opening up dual-track uation oriented toward both "paper publication" and "industrial contribution."

Going forward, the Cell Valley Group will take this symposium as an opportunity to continue basing itself in Pingshan, using core technology as a fulcrum, deepening hospital-enterprise collaboration and innovation in talent cultivation mechanisms, and working with Pingshan to write the "next decade" of integrated development of education, science and technology, and talent, enabling more original innovations to take root and grow in this soil.